Why the study?
Many HF trials do not report baseline comorbidities, highlighting the need to evaluate comorbidity reporting and recruitment of multi-morbid HF patients.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
HF trial results have limited applicability to multimorbid patients; leaves open the need for standardized comorbidity reporting frameworks.
Many HF trials do not report baseline comorbidities. A more rigorous, systematic, and standardized framework needs to be adopted for future clinical trials to ensure adequate comorbidity reporting and improve recruitment of multi-morbid HF patients.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: